Fierce Pharma

Marty Makary, M.D., is resigning as FDA commissioner Tuesday, ending [...]

CSL has slashed its revenue projection for the fiscal year [...]

Eversana Intouch, the AI-powered marketing agency arm of Eversana, pulled [...]

During the weeklong stay by the Supreme Court to temporarily [...]

Explore how targeted protein degradation is reshaping drug discovery, enabling [...]

Gilead raised its previous guidance of $800 million in revenues [...]

With an eye on the lucrative U.S. market, Italy’s Angelini [...]

After a surprise rejection in January, the FDA has agreed [...]

With a better-than-expected first quarter in the books, Pfizer—continuing to [...]

Novartis is continuing its multiyear overhaul with new plans to [...]